close

Enter

Log in using OpenID

Cell Line Development Market To Set New Record Growth By The End Of 2026

embed
North America To Dominate The Market For Cell Line Development Due To High Investment In Research By Pharmaceutical Companies To Develop Novel Product
Cell Line Development Market Review,
Outlook, Future Analysis And Synthesis
By 2026
Cell line is a permanently established cell culture, which proliferates in fresh medium. Cell line
development is utilized for examining efficiency of drug discovery and toxicity. It is essential for the
production of recombinant proteins production such as, monoclonal antibodies, bi-specific monoclonal
antibodies, growth factors, and enzymes using a wide variety of expression systems. Cell lines saves the
crucial time, effort and cost by providing the high yield cells which can be used for in vitro testing and
reduce chance of research drug to fail in clinical trial stage.
Development of novel therapy to drive growth of the cell line development market
Cell line development has wide application areas. Development of immunotherapy for the treatment of
cancer is major application of cell line development. According to the World Health Organization
factsheet 2012, cancer is one of the leading cause of death from top three causes of non-communicable
disease. Pharmaceutical and biotechnological companies are focusing on developing novel therapies such
as immunotherapy due to its specificity and efficiency. Cell line development helps in speeding drug
discovery process and optimization of clinical trials by providing high yield of monoclonal antibodies,
which is expected to fuel growth of the cell line development market.
Download PDF Brochure of This Business report @
https://www.coherentmarketinsights.com/insight/request-pdf/1286
North America to dominate the market for cell line development due to high investment in
research by pharmaceutical companies to develop novel product
North America is expected to hold the dominant position in the global cell line development
market, owing to high investment by pharmaceutical companies in developing a novel treatment
product and increasing off patenting of major products, which would promote biosimilar drug
development. Biosimilar drug having biological molecule needs to match in structure and
composition with original product which needs cell line to confirm matching of structure and
adhere to quality attribute such as glycoprofile, protein aggregation. For instance, according to
2016 report of International Trade Administration of Department of Commerce (USA), the U.S.
generic drug sales reached an estimated US$ 70 billion in 2015, which represents quarter of the
global market, due to a large number of drugs going off-patent and healthcare reforms favoring
generics development.
Report includes chapters which deeply display the following deliverable about industry :
• Cell Line Development Market Research Objective and Assumption
• Cell Line Development Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Cell Line Development Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Cell Line Development Market, By Regions
• Cell Line Development Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Cell Line Development Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Cell Line Development Market Manufacturing Cost Analysis including Key Raw Materials and
Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Cell Line Development Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Collaborations by cell line development companies with drug discovery companies to speed up
expansion of cell line development market
Some of the major players operating in the global cell line development market includ e Lonza
Group AG, Sigma-Aldrich Corporation, Wuxi App Tec, Inc., American Type Culture Collection, Thermo
Fisher Scientific, Inc., PX’Therapeutics SA., Selexis SA, GE Healthcare, European Collection of Cell
Cultures , Corning, Inc., Sartorious AG, Goodwin Biotechnology Inc., and Cleancells.
Cell Line Development Market Taxonomy
On the basis of Product type:
• Reagents & Media
• Equipment
On the basis of source:
• Mammalian
• Non-Mammalian
On the basis of cell line:
• Recombinant
• Hybridomas
• Continuous Cell Line
• Primary Cell Line
On the basis of application:
• Bioproduction
• Drug Discovery
• Toxicity Testing
• Tissue Engineering
• Research
Browse Full Report @ https://www.coherentmarketinsights.com/ongoing-insight/cell-linedevelopment-market-1286
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Author
Poul Master
Poul Master211   documents Email
Document
Category
Health and Medicine
Views
13
File Size
344 KB
Tags
market, Cell Line Development Market
1/--pages
Report inappropriate content